![Michael Ryde](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Ryde is currently the Chief Executive Officer at Pharmacosmos Therapeutics Inc. He previously worked as the Vice President-Sales at Pharmacosmos A.
| Empresas | Cargo | Inicio |
|---|---|---|
Pharmacosmos Therapeutics Inc.
 Pharmacosmos Therapeutics Inc. BiotechnologyHealth Technology Develops treatments for patients suffering from iron deficiency and anemia | Director Ejecutivo | - |
| Empresas | Cargo | Fin |
|---|---|---|
Pharmacosmos A/S
 Pharmacosmos A/S BiotechnologyHealth Technology Engages in development of treatments for patients suffering from iron deficiency and anemia | Ventas & Marketing | 01/01/2020 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
| Empresas privadas | 2 |
|---|---|
Pharmacosmos A/S
Pharmacosmos A/S BiotechnologyHealth Technology Engages in development of treatments for patients suffering from iron deficiency and anemia | Health Technology |
Pharmacosmos Therapeutics Inc.
Pharmacosmos Therapeutics Inc. BiotechnologyHealth Technology Develops treatments for patients suffering from iron deficiency and anemia | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
